Hester Biosciences Limited (HESTERBIO) Stock Statistics & Valuation Metrics

Hester Biosciences Limited has a market cap or net worth of ₹15.83B. The enterprise value is ₹18.04B.

Hester Biosciences Limited has 8,506,865 shares outstanding. The number of shares has decreased by -2.65% in one year.

Hester Biosciences Limited’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 19.86%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Hester Biosciences Limited had revenue of 3.11B and earned 274.88M in profits. Earnings per share was 33.89.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Hester Biosciences Limited pays an annual dividend of ₹6, resulting in a dividend yield of 0.32%

Hester Biosciences Limited upcoming earnings date is Aug 14, 2025, TBA (Confirmed).

Hester Biosciences Limited as a current ratio of 1.56, with Debt / Equity ratio of 67.86%

In the past 12 months, Hester Biosciences Limited has paid 107.45M in taxes.

Hester Biosciences Limited EV to EBITDA ratio is 21.76, with an EV/FCF ratio of 32.19.

Hester Biosciences Limited has ₹72.19M in cash and marketable securities with ₹2.13B in debt, giving a net cash position of ₹2.06B billion.

Gross margin is 56.45%, with operating margin of 52.81%, and net profit margin of 8.84%.

The average price target for Hester Biosciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―